mhurhangee/ep-ind-claims huggingface dataset:
A system for delivering acoustic energy to a clot, the system comprising: a. a focused-ultrasound phased-array transducer; b. an imager for capturing images; c. a processor adapted to receive the images transferred from the imager for monitoring clinical parameters related to the clot and wherein the processor is adapted to (i) automatically analyze images using image-analysis software configured to recognize fluid flow through or liquid content of the clot and estimate liquid content of the clot as ultrasound energy is directed at the clot, (ii) based on the image analysis, liquid content and focal quality of the images, generate correction factors for altering the intensity and/or pressure of the ultrasound energy and (iii) repeat steps (i) and (ii) until the clot is substantially liquefied; and d. a controller for operating the transducer in accordance with the correction factors. a. a focused-ultrasound phased-array transducer; b. an imager for capturing images; c. a processor adapted to receive the images transferred from the imager for monitoring clinical parameters related to the clot and wherein the processor is adapted to (i) automatically analyze images using image-analysis software configured to recognize fluid flow through or liquid content of the clot and estimate liquid content of the clot as ultrasound energy is directed at the clot, (ii) based on the image analysis, liquid content and focal quality of the images, generate correction factors for altering the intensity and/or pressure of the ultrasound energy and (iii) repeat steps (i) and (ii) until the clot is substantially liquefied; and d. a controller for operating the transducer in accordance with the correction factors.
A body tissue substitute selected from artificial skin and artificial mucosa, comprising: - a substrate comprising an outer surface, - a cell layer covering at least part of the outer surface, the cell layer comprising a monolayer of skin or mucous membrane cells, having a thickness, a first face and a second outer face, opposite the first face, the first face and the second face extending transversely to the thickness of the cell layer, the cellular layer being arranged with the first face in contact with the outer surface of the substrate, and - at least one pore extending through the cellular layer and opening onto the second face of the cellular layer, wherein the substrate comprises a pipe adapted to connect the pore to a liquid injection system. - a substrate comprising an outer surface, - a cell layer covering at least part of the outer surface, the cell layer comprising a monolayer of skin or mucous membrane cells, having a thickness, a first face and a second outer face, opposite the first face, the first face and the second face extending transversely to the thickness of the cell layer, the cellular layer being arranged with the first face in contact with the outer surface of the substrate, and - at least one pore extending through the cellular layer and opening onto the second face of the cellular layer,
A high voltage terminal cooling structure, comprising: a high voltage terminal; at least one first heat pipe which includes a first end portion and a second end portion; a heat transfer mechanism which is in contact with both the high voltage terminal and the first end portion; and a heat dissipation mechanism (2, 5) the heat dissipation mechanism (2, 5) which is in contact with the second end portion is one selected from: a cold plate which includes an inlet and an outlet for a coolant; or a heat sink which includes a plurality of fins arranged in parallel, characterized in that, the heat transfer mechanism is a vapor chamber which is in contact with the first end portion, the vapor chamber includes a container having conductivity and into which a working fluid and a wick are enclosed, the vapor chamber also includes an insulator (23, 26) that electrically insulates the high voltage terminal and the first heat pipe from each other, and the insulator (23, 26) is positioned between the container and the first heat pipe and between the container and the high voltage terminal. a high voltage terminal; at least one first heat pipe which includes a first end portion and a second end portion; a heat transfer mechanism which is in contact with both the high voltage terminal and the first end portion; and a heat dissipation mechanism (2, 5) the heat dissipation mechanism (2, 5) which is in contact with the second end portion is one selected from: a cold plate which includes an inlet and an outlet for a coolant; or a heat sink which includes a plurality of fins arranged in parallel, characterized in that, a cold plate which includes an inlet and an outlet for a coolant; or a heat sink which includes a plurality of fins arranged in parallel, characterized in that, the heat transfer mechanism is a vapor chamber which is in contact with the first end portion, the vapor chamber includes a container having conductivity and into which a working fluid and a wick are enclosed, the vapor chamber also includes an insulator (23, 26) that electrically insulates the high voltage terminal and the first heat pipe from each other, and the insulator (23, 26) is positioned between the container and the first heat pipe and between the container and the high voltage terminal.
A process for the manufacture of mineral wool comprising: - a melting stage which makes it possible to obtain a molten glass, the chemical composition of which comprises the following constituents, in a content by weight varying within the limits defined below: SiO 2 39-55% Al 2 O 3 16-27% CaO 3-35% MgO 0-5% Na 2 O+K 2 O 9-17% Fe 2 O 3 0-15% B 2 O 3 0-8% said melting stage being carried out by electric melting in a furnace comprising a tank made of refractory blocks and at least two electrodes immersed in the molten glass, said refractory blocks forming the sidewalls of the tank, in contact with said molten glass, being made of a material comprising at least 60% by weight of zirconium oxide and less than 5% by weight of chromium oxide, then - a stage of fiberizing said molten glass. - a melting stage which makes it possible to obtain a molten glass, the chemical composition of which comprises the following constituents, in a content by weight varying within the limits defined below: SiO 2 39-55% Al 2 O 3 16-27% CaO 3-35% MgO 0-5% Na 2 O+K 2 O 9-17% Fe 2 O 3 0-15% B 2 O 3 0-8% said melting stage being carried out by electric melting in a furnace comprising a tank made of refractory blocks and at least two electrodes immersed in the molten glass, said refractory blocks forming the sidewalls of the tank, in contact with said molten glass, being made of a material comprising at least 60% by weight of zirconium oxide and less than 5% by weight of chromium oxide, then - a stage of fiberizing said molten glass.
An apparatus for recording physiological signal, comprising: a storage unit, configured for storing a physiological signal of a user during a time interval; a signal analyzer, configured for analyzing the physiological signal of the user to provide an analysis result; and a controller, configured for changing the time interval according to the analysis result, characterised in that the time interval is changed by separating the time interval into a plurality of intervals, wherein the analysis result is indicative of one of the following: whether the physiological signal is unreliable, whether the physiological signal is noisy, whether morphology of the physiological signal is abnormal, whether rhythm of the physiological signal is abnormal, and whether the physiological signal is normal, wherein the physiological signal of the user is an electrocardiography signal or a photoplethysmography signal. a storage unit, configured for storing a physiological signal of a user during a time interval; a signal analyzer, configured for analyzing the physiological signal of the user to provide an analysis result; and a controller, configured for changing the time interval according to the analysis result, characterised in that the time interval is changed by separating the time interval into a plurality of intervals, wherein the analysis result is indicative of one of the following: whether the physiological signal is unreliable, whether the physiological signal is noisy, whether morphology of the physiological signal is abnormal, whether rhythm of the physiological signal is abnormal, and whether the physiological signal is normal, wherein the physiological signal of the user is an electrocardiography signal or a photoplethysmography signal.
Arrangement having a first compressor train and a second compressor train for compressing a process fluid, wherein the first compressor train comprises a first drive and a first compressor, wherein the second compressor train comprises a second drive and a second compressor, wherein the first compressor train is not mechanically coupled in torque-transmitting fashion to rotating parts of the second compressor train, wherein the two compressors (CO1, CO2) of the different compressor trains (CT1, CT2) are directly connected in fluid-conducting fashion to one another by means of a connecting fluid line, in such a way that the first compressor is arranged upstream of the second compressor, and wherein the first compressor compresses with a pressure ratio between 1.1 and 1.6 before the process fluid is fed to the second compressor, characterized in that the second compressor is in the form of a geared compressor.
A system, comprising: a shape sensing enabled device including one or more imaging devices, the shape sensing enabled device coupled to at least one optical fiber; a shape sensing module configured to receive optical signals from the at least one optical fiber within a structure and interpret the optical signals to determine a shape of the shape sensing enabled device; a device positioning module configured to determine position information of the one or more imaging devices based upon one or more spatial relationships between the at least one optical fiber and the one or more imaging devices; and a mapping module configured to register frames of reference of the at least one optical fiber, the shape sensing enabled device, and a mapping system of a target device to provide an adjusted position of the target device based on the position information. a shape sensing enabled device including one or more imaging devices, the shape sensing enabled device coupled to at least one optical fiber; a shape sensing module configured to receive optical signals from the at least one optical fiber within a structure and interpret the optical signals to determine a shape of the shape sensing enabled device; a device positioning module configured to determine position information of the one or more imaging devices based upon one or more spatial relationships between the at least one optical fiber and the one or more imaging devices; and a mapping module configured to register frames of reference of the at least one optical fiber, the shape sensing enabled device, and a mapping system of a target device to provide an adjusted position of the target device based on the position information.
A method for manufacturing a rotor for a rotating electrical machine, the rotor comprising: a magnetic field coil that generates magnetic flux; a plurality of slip rings (14, 14a, 14b) that supply to the magnetic field coil a field current from outside the rotor; and terminals (8, 9) that connect the slip rings (14, 14a, 14b) with the magnetic field coil; wherein the terminals (8, 9) each include a link element portion (8a, 9a) extending in a rotation axis direction and a radially-extending portion (8b, 9b) extending in a radial direction, and at an end of the radially-extending portion (8b, 9b) are provided a winding connection section connected with a lead wire of the magnetic field coil, and a positioning section that is provided circumferentially adjacently to the winding connection section and serves for positioning when molded, wherein the positioning section is formed in a protruding shape and provided with a radially inner side surface and a radially outer side surface, wherein a slip ring assembly is manufactured by integrally molding with resin said terminals (8, 9) and said slip rings (14a, 14b) in a molding die, characterized in that the radially inner side surface and the radially outer side surface of the positioning section are held by side surfaces of a stepwise section (16a, 16b) provided in the molding die during molding. a magnetic field coil that generates magnetic flux; a plurality of slip rings (14, 14a, 14b) that supply to the magnetic field coil a field current from outside the rotor; and terminals (8, 9) that connect the slip rings (14, 14a, 14b) with the magnetic field coil; wherein the terminals (8, 9) each include a link element portion (8a, 9a) extending in a rotation axis direction and a radially-extending portion (8b, 9b) extending in a radial direction, and at an end of the radially-extending portion (8b, 9b) are provided a winding connection section connected with a lead wire of the magnetic field coil, and a positioning section that is provided circumferentially adjacently to the winding connection section and serves for positioning when molded, wherein the positioning section is formed in a protruding shape and provided with a radially inner side surface and a radially outer side surface, wherein a slip ring assembly is manufactured by integrally molding with resin said terminals (8, 9) and said slip rings (14a, 14b) in a molding die, characterized in that the radially inner side surface and the radially outer side surface of the positioning section are held by side surfaces of a stepwise section (16a, 16b) provided in the molding die during molding.
Method for encoding at least one image (I N) divided into partitions (PA1, PA2,..., PAn), characterized in that it implements, for a current partition (PAc) to be encoded, steps of: - selecting at least one causal partition (PAi r, Pati r) already encoded then decoded, said at least one causal partition being found in an image decoded prior to said image; - computing at least one optimal encoding parameter of said at least one selected causal partition, in order to optimize a predetermined encoding-performance criterion of an encoding of the causal partition, via competition between a plurality of encoding parameters applied to said at least one selected causal partition; - encoding the current partition using said at least one computed optimal encoding parameter of said at least one selected causal partition. - selecting at least one causal partition (PAi r, Pati r) already encoded then decoded, said at least one causal partition being found in an image decoded prior to said image; - computing at least one optimal encoding parameter of said at least one selected causal partition, in order to optimize a predetermined encoding-performance criterion of an encoding of the causal partition, via competition between a plurality of encoding parameters applied to said at least one selected causal partition; - encoding the current partition using said at least one computed optimal encoding parameter of said at least one selected causal partition.
A spherical plain bearing assembly, comprising: a ball having a first groove located in an outer surface thereof; an outer race having an outer surface and an inner engagement surface, the inner engagement surface positioned on a portion of the outer surface of the ball and contoured to a shape complementary to the outer surface of the ball such that the outer surface of the ball is slidably and rotatably engaged with the inner engagement surface, and the outer surface of the outer race having a second groove located therein, the first and second grooves being concentrically arranged; characterised by, a first ring (50, 150) slidably located in one of the first groove and the second groove, the first ring (50, 150) having a substantially U-shaped cross sectional geometry defined by a first leg and a second leg, the first ring (50, 150) further comprising a lip protruding substantially perpendicularly from one of the first leg and the second leg; and a seal rotatable relative to the ball, the seal having a first edge and a second edge, the first edge being captured in the first ring (50, 150) by the first leg and the second leg, and the second edge being captured in the other of the first groove and the second groove, the first ring (50, 150) and the seal moving substantially in concert with each other eliminating resistant forces between the seal and the ball. a ball having a first groove located in an outer surface thereof; an outer race having an outer surface and an inner engagement surface, the inner engagement surface positioned on a portion of the outer surface of the ball and contoured to a shape complementary to the outer surface of the ball such that the outer surface of the ball is slidably and rotatably engaged with the inner engagement surface, and the outer surface of the outer race having a second groove located therein, the first and second grooves being concentrically arranged; characterised by, a first ring (50, 150) slidably located in one of the first groove and the second groove, the first ring (50, 150) having a substantially U-shaped cross sectional geometry defined by a first leg and a second leg, the first ring (50, 150) further comprising a lip protruding substantially perpendicularly from one of the first leg and the second leg; and a seal rotatable relative to the ball, the seal having a first edge and a second edge, the first edge being captured in the first ring (50, 150) by the first leg and the second leg, and the second edge being captured in the other of the first groove and the second groove, the first ring (50, 150) and the seal moving substantially in concert with each other eliminating resistant forces between the seal and the ball.
A pulmonary delivery apparatus comprising: a first vaporiser adapted to vaporise a quantity of a first liquid, and a second vaporiser adapted to vaporise a quantity of a second liquid, the second liquid being a different liquid to the first liquid and wherein one or both the first or second liquids comprises an active molecule, excipient or medicament; and an outlet via which, in use, a user can inhale a mixture of the first and second vapours and being characterised by: a programmable controller adapted to automatically control, in use, the ratio of the first and second liquids in the mixture to change the ratio of the liquids on a dose dependent basis.
A conjugate comprising an isolated antigen-binding protein which binds claudin-6 or antigen-binding fragment thereof, a cytotoxic agent or a chemotherapeutic agent and a linker, wherein the antigen-binding protein is selected from: (a) an antigen-binding protein comprising: (i) an HC CDR1 comprising the amino acid sequence of FTFSXYX (SEQ ID NO: 455), wherein X at position 5 is N and X at position 7 is W; (ii) an HC CDR2 comprising the amino acid sequence of IRLKXDXYAT (SEQ ID NO: 456), wherein X at position 5 is S and X at position 7 is N; (iii) an HC CDR3 comprising the amino acid sequence of XDGPPSGX (SEQ ID NO: 457), wherein X at position 1 is N and X at position 8 is S; (iv) an LC CDR1 comprising the amino acid sequence of EXIYSY (SEQ ID NO: 476), wherein X is N; (v) an LC CDR2 comprising the amino acid sequence of XAK (SEQ ID NO: 477), wherein X at position 1 is N; and (vi) an LC CDR3 comprising the amino acid sequence of QXHYXVPWT (SEQ ID NO: 454), wherein X at position 2 is H and X at position 5 is T; and (b) an antigen-binding protein comprising the heavy chain CDR1-3 amino acid sequences of SEQ ID NOs: 23, 24, and 25, and the light chain CDR1-3 amino acid sequences of SEQ ID NOs: 20, 21, and 22, wherein the linker is between the antibody and the cytotoxic agent or chemotherapeutic agent and the linker is selected from the group consisting of VC-PAB, GGFG and CL2A. (a) an antigen-binding protein comprising: (i) an HC CDR1 comprising the amino acid sequence of FTFSXYX (SEQ ID NO: 455), wherein X at position 5 is N and X at position 7 is W; (ii) an HC CDR2 comprising the amino acid sequence of IRLKXDXYAT (SEQ ID NO: 456), wherein X at position 5 is S and X at position 7 is N; (iii) an HC CDR3 comprising the amino acid sequence of XDGPPSGX (SEQ ID NO: 457), wherein X at position 1 is N and X at position 8 is S; (iv) an LC CDR1 comprising the amino acid sequence of EXIYSY (SEQ ID NO: 476), wherein X is N; (v) an LC CDR2 comprising the amino acid sequence of XAK (SEQ ID NO: 477), wherein X at position 1 is N; and (vi) an LC CDR3 comprising the amino acid sequence of QXHYXVPWT (SEQ ID NO: 454), wherein X at position 2 is H and X at position 5 is T; and (i) an HC CDR1 comprising the amino acid sequence of FTFSXYX (SEQ ID NO: 455), wherein X at position 5 is N and X at position 7 is W; (ii) an HC CDR2 comprising the amino acid sequence of IRLKXDXYAT (SEQ ID NO: 456), wherein X at position 5 is S and X at position 7 is N; (iii) an HC CDR3 comprising the amino acid sequence of XDGPPSGX (SEQ ID NO: 457), wherein X at position 1 is N and X at position 8 is S; (iv) an LC CDR1 comprising the amino acid sequence of EXIYSY (SEQ ID NO: 476), wherein X is N; (v) an LC CDR2 comprising the amino acid sequence of XAK (SEQ ID NO: 477), wherein X at position 1 is N; and (vi) an LC CDR3 comprising the amino acid sequence of QXHYXVPWT (SEQ ID NO: 454), wherein X at position 2 is H and X at position 5 is T; and (b) an antigen-binding protein comprising the heavy chain CDR1-3 amino acid sequences of SEQ ID NOs: 23, 24, and 25, and the light chain CDR1-3 amino acid sequences of SEQ ID NOs: 20, 21, and 22,